CMR, one of multiple companies competing for a portion of the growing market in robotically assisted surgery, claims that Versius is the second most utilized soft tissue robot worldwide ...

CMR is anticipating the broadening of its clinical footprint through two ongoing trials, a multi-centre prospective study of Versius in paediatric surgery and a transoral robotic surgery (TORS ...

Johnson & Johnson plans to seek a U.S. indication for multiple general surgery procedures, including gastric bypass, which ...

CMR Surgical has closed a financing round of more than $200 million, backed by existing investors and new investor Trinity Capital The latest funding will fuel the global commercialisation of its ...

NHS surgeons in England will be able to use surgical robotic systems that will improve the care of patients undergoing a ...

CMR is eyeing up a launch of Versius in the US after successfully closing the round. The new finance means that the company has raised a total of more than $1.19billion in funding across eight rounds ...

CMR is also actively expanding its clinical footprint with two ongoing clinical trials: a pioneering paediatrics study, which is the world’s first multicentre prospective trial on the use of Versius ...

Morningstar brands and products Company Portfolio ...